Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial

Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial

The specificity and implementation of current MRI-based diagnostic criteria for multiple sclerosis (MS) are imperfect. Approximately 1 in 5 of individuals diagnosed with MS are eventually determined not to have the disease, with overreliance on MRI findings a major cause of MS misdiagnosis. The cent...

Full description

Bibliographic Details
Main Authors: D. Ontaneda, P. Sati, P. Raza, M. Kilbane, E. Gombos, E. Alvarez, C. Azevedo, P. Calabresi, J.A. Cohen, L. Freeman, R.G. Henry, E.E. Longbrake, N. Mitra, N. Illenberger, M. Schindler, D. Moreno-Dominguez, M. Ramos, E. Mowry, J. Oh, P. Rodrigues, S. Chahin, M. Kaisey, E. Waubant, G. Cutter, R. Shinohara, D.S. Reich, A. Solomon, N.L. Sicotte
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:NeuroImage: Clinical
Subjects:
Multiple sclerosis
MRI
Biomarker
Diagnosis
Central vein
Demyelinating disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158221002783

Similar Items

Similar Items